ArticlePloS one2025
Machine learning-based transcriptomic analysis identifies NAMPT and SAT1 as potential biomarkers and therapeutic targets in ferroptosis-associated rheumatoid arthritis.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Global research trends in programmed cell death in rheumatoid arthritis from 2001 to 2025: a bibliometric analysis.Frontiers in immunology · 2026Pooled it
- Multi-omics-driven biomarker discovery in autoimmune diseases: a comprehensive review.Frontiers in immunology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRheumatoid arthritis (RA) is an autoimmune disease with chronic presentation, involving symmetric joints and systemic involvement. Ferroptosis is iron-dependent programmed cell death through lipid peroxide accumulation, implicated in inflammatory diseases, including RA. However, its underlying mechanisms and gene-level contributions to RA pathogenesis remain largely unexplored. Therefore, this study emphasizes identifying ferroptosis-related genes associated with RA, evaluating their diagnostic, prognostic, and therapeutic potential, and exploring their role in immune modulation.
methodsThe transcriptomic dataset (GSE89408) from the peripheral blood gene expression was downloaded from the Gene Expression Omnibus (GEO) database. We extracted the differentially expressed genes (DEGs) using R software and the most relevant modules relevant to RA were identified through weighted gene coexpression network analysis (WGCNA). We also identified the differentially expressed ferroptosis genes. The gene ontology and pathways involving the common genes were identified and the protein-protein interaction network was constructed. The hub genes were identified using three machine learning algorithms, least absolute shrinkage and selection operator (LASSO), random forest (RF), and support vector machine (SVM), after which the diagnostic efficiency of the hub genes and the correlation with immune infiltrating cells were predicted.
resultsA total of 9176 DEGs and a module of 314 genes were obtained which has a significant correlation with RA and 17 genes were selected after the intersection. Using the three machine-learning algorithms, we retrieved 8 hub genes (CISD2, LACTB, PRNP, SAT1, NAMPT, MITD1, SOD2, and FASN) between RA and ferroptosis which showed good diagnostic performance using the ROC curve and nomogram plots. Functional annotation analysis was utilized to inspect the biological functions of the hub genes and the genes showed a substantial association with the immune infiltrating cells.
conclusionNAMPT, CISD2, LACTB, PRNP, SAT1, SOD2, MITD1, and FASN may modulate ferroptosis and RA by influencing immunity, and NAMPT and SAT1 contribute significantly to the diagnosis and treatment of the disease. Future studies focusing on validating these genes in larger cohorts and exploring their therapeutic potential will provide deeper insights.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.